Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai
Patent
1985-10-16
1988-08-09
Brown, J. R.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Carbohydrate doai
536 23, A61K 3170, C07H 1906
Patent
active
047628235
ABSTRACT:
A method for synthesizing monofluoromethyl- and difluoromethyluracil nucleosides from the corresponding thymine nucleosides is developed. These compounds which contain a partially fluorinated methyl group at the C-5 position (a new class of nucleosides) are potential antiviral and/or anticancer agents. The major features of the preparative route involve bromination of suitably protected thymine nucleosides followed by fluoride treatment.
REFERENCES:
patent: 3870700 (1975-03-01), Kotick et al.
patent: 4140850 (1979-02-01), Wierenga
patent: 4210638 (1980-07-01), Greer
patent: 4334059 (1982-06-01), Ogilvie
patent: 4382925 (1983-05-01), deClercq et al.
patent: 4594339 (1986-06-01), Lopez et al.
Fox Jack J.
Matulic-Adamic Jasenka
Price Richard W.
Watanabe Kyoichi A.
Brown J. R.
Sloan-Kettering Institute for Cancer Research
Tou Jenny
White John P.
LandOfFree
Nucleosides of 5-monofluoromethyluracil and 5-difluoromethylurac does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Nucleosides of 5-monofluoromethyluracil and 5-difluoromethylurac, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Nucleosides of 5-monofluoromethyluracil and 5-difluoromethylurac will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-918674